Medicine
Tamsulosin 0.4 mg capsule
Tamsulosin 0.4 mg capsule is a generic prescription medicine for oral use, made by 34 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C - 30°C (59°F - 86°F).
Key facts
- Active ingredient (INN)
- Tamsulosin
- Brand
- Sold under the generic name
- Strength
- 0.4 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 30 capsules and 204 more
- Manufacturers
- Zydus LifesciencesIndiaAscend LaboratoriesIndiaSun Pharmaceutical IndustriesIndiaMacleods PharmaceuticalsIndiaAurobindo PharmaIndiaXLCare PharmaceuticalsAmneal Pharmaceuticals of New York34 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C - 30°C (59°F - 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04CA02 Tamsulosin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 April 2010
- Identifiers
- RxCUI 863669DailyMed set ID 9108b999-4b99-469d-99a8-5ef0fa4ca00a, db6cb771-2cff-40b7-a5ef-ea3cf2a3b461, 7275902e-6832-4e71-997a-d1f7fc1c6a11 +37NDC 72865-282, 76282-744, 63187-358 +37Application ANDA214730, ANDA078801, ANDA202433 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 34 labelers. The register lists 207 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 65841-695-01 | Zydus LifesciencesIndia | 27 April 2010 |
| 500 capsule in 1 bottle | 65841-695-05 | Zydus LifesciencesIndia | 27 April 2010 |
| 30 capsule in 1 bottle | 65841-695-06 | Zydus LifesciencesIndia | 27 April 2010 |
| 1000 capsule in 1 bottle | 65841-695-10 | Zydus LifesciencesIndia | 27 April 2010 |
| 60 capsule in 1 bottle | 65841-695-14 | Zydus LifesciencesIndia | 27 April 2010 |
| 90 capsule in 1 bottle | 65841-695-16 | Zydus LifesciencesIndia | 27 April 2010 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 65841-695-77 | Zydus LifesciencesIndia | 27 April 2010 |
| 100 capsule in 1 bottle | 68382-132-01 | Zydus LifesciencesIndia | 27 April 2010 |
| 500 capsule in 1 bottle | 68382-132-05 | Zydus LifesciencesIndia | 27 April 2010 |
| 30 capsule in 1 bottle | 68382-132-06 | Zydus LifesciencesIndia | 27 April 2010 |
| 1000 capsule in 1 bottle | 68382-132-10 | Zydus LifesciencesIndia | 27 April 2010 |
| 60 capsule in 1 bottle | 68382-132-14 | Zydus LifesciencesIndia | 27 April 2010 |
| 90 capsule in 1 bottle | 68382-132-16 | Zydus LifesciencesIndia | 27 April 2010 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 68382-132-77 | Zydus LifesciencesIndia | 27 April 2010 |
| 100 capsule in 1 bottle | 67877-450-01 | Ascend LaboratoriesIndia | 11 August 2017 |
| 500 capsule in 1 bottle | 67877-450-05 | Ascend LaboratoriesIndia | 11 August 2017 |
| 1000 capsule in 1 bottle | 67877-450-10 | Ascend LaboratoriesIndia | 11 August 2017 |
| 30 capsule in 1 bottle | 67877-450-30 | Ascend LaboratoriesIndia | 11 August 2017 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 67877-450-38 | Ascend LaboratoriesIndia | 11 August 2017 |
| 60 capsule in 1 bottle | 67877-450-60 | Ascend LaboratoriesIndia | 11 August 2017 |
| 100 capsule in 1 bottle | 65862-598-01 | Aurobindo PharmaIndia | 30 April 2013 |
| 500 capsule in 1 bottle | 65862-598-05 | Aurobindo PharmaIndia | 30 April 2013 |
| 3 blister pack in 1 carton / 10 capsule in 1 blister pack | 65862-598-10 | Aurobindo PharmaIndia | 30 April 2013 |
| 30 capsule in 1 bottle | 33342-159-07 | Macleods PharmaceuticalsIndia | 25 January 2017 |
| 100 capsule in 1 bottle | 33342-159-11 | Macleods PharmaceuticalsIndia | 25 January 2017 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 33342-159-12 | Macleods PharmaceuticalsIndia | 25 January 2017 |
| 500 capsule in 1 bottle | 33342-159-15 | Macleods PharmaceuticalsIndia | 25 January 2017 |
| 1000 capsule in 1 bottle | 33342-159-44 | Macleods PharmaceuticalsIndia | 25 January 2017 |
| 100 capsule in 1 bottle | 62756-160-08 | Sun Pharmaceutical IndustriesIndia | 15 July 2010 |
| 500 capsule in 1 bottle | 62756-160-13 | Sun Pharmaceutical IndustriesIndia | 15 July 2010 |
| 1000 capsule in 1 bottle | 62756-160-18 | Sun Pharmaceutical IndustriesIndia | 15 July 2010 |
| 90 capsule in 1 bottle | 62756-160-81 | Sun Pharmaceutical IndustriesIndia | 15 July 2010 |
| 30 capsule in 1 bottle | 62756-160-83 | Sun Pharmaceutical IndustriesIndia | 15 July 2010 |
| 100 capsule in 1 bottle | 62756-160-88 | Sun Pharmaceutical IndustriesIndia | 15 July 2010 |
| 100 capsule in 1 bottle | 72865-282-01 | XLCare Pharmaceuticals | 10 September 2024 |
| 500 capsule in 1 bottle | 72865-282-05 | XLCare Pharmaceuticals | 26 February 2025 |
| 90 capsule in 1 bottle | 72865-282-90 | XLCare Pharmaceuticals | 26 February 2025 |
| 500 capsule in 1 bottle | 72865-350-05 | XLCare Pharmaceuticals | 1 January 2026 |
| 90 capsule in 1 bottle | 72865-350-90 | XLCare Pharmaceuticals | 1 January 2026 |
| 100 capsule in 1 bottle | 0115-8211-01 | Amneal Pharmaceuticals of New York | 1 April 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 April 1997 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Tamsulosin is an alpha-adrenergic blocker indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), among other approved uses. It is available as capsules for oral use. MedsAcross supplies Tamsulosin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TamsulosinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tamsulosin hydrochloride prescribing information (Synthon) · U.S. National Library of Medicine, DailyMed
Need Tamsulosin 0.4 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.